TRELSTAR (nda020715)- (EQ 3.75MG BASE/VIAL)

Generic Name	TRIPTORELIN PAMOATE	Innovator	VERITY
Dosage	EQ 3.75MG BASE/VIAL
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	2015-Jul-07	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	TRELSTAR is a gonadotropin releasing hormone (GnRH) agonist indicated for the palliative treatment of advanced prostate cancer.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 3.75MG BASE/VIAL	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of TRELSTAR